Virtu Financial’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,218
Closed -$672K 1655
2025
Q4
$672K Buy
+2,218
New +$692K 0.03% 484
2024
Q3
Sell
-1,494
Closed -$408K 1383
2024
Q2
$408K Buy
+1,494
New +$435K 0.03% 499
2024
Q1
Sell
-1,022
Closed -$330K 1425
2023
Q4
$330K Buy
+1,022
New +$320K 0.03% 570
2022
Q4
Sell
-3,010
Closed -$1.25M 1623
2022
Q3
$1.25M Buy
3,010
+1,576
+110% +$786K 0.12% 147
2022
Q2
$710K Buy
+1,434
New +$747K 0.06% 284
2020
Q3
Sell
-1,653
Closed -$746K 1071
2020
Q2
$746K Buy
+1,653
New +$729K 0.09% 254
2019
Q4
Sell
-818
Closed -$272K 1445
2019
Q3
$272K Buy
+818
New +$267K 0.02% 807
2019
Q2
Sell
-5,414
Closed -$1.66M 1467
2019
Q1
$1.66M Buy
+5,414
New +$1.46M 0.09% 179
2018
Q4
Sell
-944
Closed -$295K 1558
2018
Q3
$295K Sell
944
-236
-20% -$73.3K 0.02% 859
2018
Q2
$340K Buy
+1,180
New +$326K 0.02% 1065
2018
Q1
Sell
-4,324
Closed -$1.03M 1963
2017
Q4
$1.03M Buy
4,324
+1,994
+86% +$483K 0.05% 424
2017
Q3
$518K Buy
+2,330
New +$524K 0.03% 906

Other funds holding BIO

Virtu Financial's BIO Position: Q1 2026 in Review

Virtu Financial sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2026, closing a stake of 2,218 shares — an estimated $672K sold.

Virtu Financial first reported a position in BIO in Q3 2017 and held it in 12 quarters. The position peaked at $1.66M in Q1 2019. 395 funds tracked by Wall St. Rank hold BIO as of Q1 2026.

  • Virtu Financial reported no remaining Bio-Rad Laboratories Class A position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 2,218 Bio-Rad Laboratories Class A shares in Q1 2026, an estimated $672K.
  • Virtu Financial first reported a position in Bio-Rad Laboratories Class A in Q3 2017 and held it in 12 quarters.
  • Virtu Financial's Bio-Rad Laboratories Class A position peaked at $1.66M in Q1 2019.
  • 395 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.